Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRTY Trial: PET-Guided Radiotherapy Consolidation in mHSPC
NCT06244004Phase 2Recruiting
- Sponsor
- Northwestern University
- Start
- Feb 2024
- Primary completion
- Feb 2027
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in prostate cancer (PCa) (6 arms), sponsored by Northwestern University. Primary endpoints: Progression Free Survival up to 36 months and Complete Response Rate at 6 months. Started Feb 2024; status: recruiting.
02
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT06244004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06244004.